RegentAtlantic Capital’s Novavax NVAX Stock Holding History

RegentAtlantic Capital’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,000	Closed	-$33K	–	441
2019 Q1	$33K	Sell	3,000 -1,000	-25%	-$31.6K	﹤0.01%	433
2018 Q4	$147K	Hold	4,000	–	–	0.01%	397
2018 Q3	$150K	Hold	4,000	–	–	0.01%	426
2018 Q2	$107K	Buy	+4,000	New	+$135K	0.01%	401

Other funds holding NVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RegentAtlantic Capital's NVAX Position: Q2 2019 in Review

RegentAtlantic Capital sold out of Novavax (NVAX) in Q2 2019, closing a stake of 3,000 shares — an estimated $33K sold.

RegentAtlantic Capital first reported a position in NVAX in Q2 2018 and held it in 4 quarters. The position peaked at $150K in Q3 2018. 81 funds tracked by Wall St. Rank hold NVAX as of Q2 2019.

RegentAtlantic Capital reported no remaining Novavax position as of Q2 2019 after selling out during the quarter.
RegentAtlantic Capital sold 3,000 Novavax shares in Q2 2019, an estimated $33K.
RegentAtlantic Capital first reported a position in Novavax in Q2 2018 and held it in 4 quarters.
RegentAtlantic Capital's Novavax position peaked at $150K in Q3 2018.
81 funds tracked by Wall St. Rank held Novavax as of Q2 2019.

Based on RegentAtlantic Capital's 13F filing for Q2 2019, filed 23 Jul 2019.